Anavex Life Sciences Corp.
HealthcareNASDAQ:AVXL · NASDAQ Global Select
+$0.00 today
Vol 1.20M · Avg 1.38M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-68.87%
Period High
$13.41
Period Low
$2.46
Latest
$2.50
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Erasca, Inc.
NASDAQ:ERAS
$4.37B
MoonLake Immunotherapeutics
NASDAQ:MLTX
$1.38B
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$1.19B
Absci Corporation
NASDAQ:ABSI
$1.06B
MeiraGTx Holdings plc
NASDAQ:MGTX
$888.13M
Astria Therapeutics, Inc.
ATXS
$718.13M
Valneva SE
NASDAQ:VALN
$507.78M
Arvinas, Inc.
NASDAQ:ARVN
$489.07M
CytomX Therapeutics, Inc.
NASDAQ:CTMX
$484.08M
REGENXBIO Inc.
NASDAQ:RGNX
$344.31M
What is the latest AVXL filing?
The latest filing shown is 8-K dated May 22, 2026.
How many recent filings does AVXL have?
Intrinsic Alpha currently shows 20 recent filings for AVXL.
Explore More
Continue the stock analysis
Jump to another research area for this company.